Not a bad read overall but yes very contingent on the authorities, I liked how ALL of the MPS patients in Brazil opt for further treatment, that's a good sign that the like the drug and are deriving benefit from it.
"Following the conclusion of Paradigm’s successful multi-centre phase 2 clinical trial,
randomising 13 MPS VI participants to iPPS or placebo, all 13 participants have elected to
continue or commence (for the placebo group) ongoing iPPS treatment".
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $184.8M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 48.0¢ | 44.0¢ | $534.2K | 1.168M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5245 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |